Pharmaceutical Sector: Sequentially Flattish Quarter Expected
4QFY22 is expected to be a flattish quarter for most Pharma companies in our coverage universe. We expect a few companies to benefit from the US...
341 Views
Indoco Remedies: Mixed Q3; Pick-Up in Exports Key Trigger
Indoco manufactures and markets branded formulations and APIs for the domestic and export markets. In domestic formulations, through its nine...
314 Views
Indoco Remedies: Stellar Numbers, Margins in Q1
Indoco manufactures and markets branded formulations and APIs for the domestic and export markets. In domestic formulations, through its nine...
272 Views
MediSetter Interview: Insight on Opportunities in Asia's Healthcare Industry
Introduction to MedisetterI had the pleasure of interviewing Anirban Lahiri of Medisetter to discuss some of the opportunities present in Asia's...
4k Views
Profit from India's Rapidly Growing Biotechnology Industry
Now is a strategic time to focus on the upside potential of biotechnology companies in India, as India’s biotechnology industry is projected to...
4.9k Views